KBB participated for the second year in a row in the 23rd InterBiz Bio Partnering & Investment Forum, Korea’s largest technology exchange and partnering event in the bio-health sector, held from July 2 to 4 at Phoenix Island, Jeju.
The event brought together around 2,200 participants from bio companies, research institutes, and investors, providing opportunities for 1:1 partnering and consulting, and establishing a platform for collaboration and global cooperation across industry, academia, research, ventures, and startups.

Last year, through this forum, KBB successfully signed three non-exclusive license agreements related to Wild-simulated Ginseng with the National Institute of Forest Science and the Korea Forestry Promotion Institute, laying the groundwork for product development and advancement of its Wild-simulated Ginseng products.

This year as well, KBB continued technical collaboration discussions with the two institutions at the forum and accelerated the commercialization of its Wild-simulated Ginseng brand ‘JIGIWON.’

KBB stated, “Through the InterBiz Forum, we are continuing technical consultations with government research institutes and plan to establish our ‘JIGIWON’ brand as Korea’s leading Wild-simulated Ginseng product,” expressing high expectations for the future.